SANGAMO THERAPEUTICS, INC.: cash_and_equivalents
| Value | {"amount": 22061000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2016-12-31) |
| Status | current |
| Entity | SANGAMO THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:41:46.934068+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/509a5992-c7f4-4bf8-a27c-54e48d21a0df
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-17-002900Retrieved: 2026-08-19T09:41:46.934068+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001001233/cash-and-equivalents/2016-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/509a5992-c7f4-4bf8-a27c-54e48d21a0df
History
- no predecessors — first report